Histone Deacetylase (HDAC) Inhibitors Market Poised for 7.5 % Growth, Set to Hit $0.82 Billion by 2029

How Is the Histone Deacetylase (HDAC) Inhibitors Market Projected to Grow, and What Is Its Market Size?
Remarkable growth has been experienced in recent years in the market size of inhibitors of histone deacetylase (HDAC). This growth is projected to continue, with the market size increasing from $1.23 billion in 2024 to $1.33 billion in 2025, at a compound annual growth rate (CAGR) of 7.9%. Several factors have contributed to this growth during the historic period, including escalated funding for epigenetic research, a surge in cases of drug-resistant cancers, increased healthcare spending, expanded use of HDAC inhibitors in veterinary medicine, and amplified investments in bioinformatics.

Projected robust expansion is anticipated in the histone deacetylase (HDAC) inhibitors market over the coming years, with its worth anticipated to reach $1.77 billion in 2029, reflecting a compound annual growth rate (CAGR) of 7.5%. The escalation during the forecast period could be linked to the increasing prevalence of neurodegenerative afflictions, heightened cancer awareness, surging investments in medication development, an expanding number of clinical experiments, and the growing acceptance of tailored medicine. Notable trends expected within the projection timeframe encompass technological breakthroughs, individualized medicine, synergies in cancer immunotherapy, the amalgamation of digital health solutions and bioinformatics.

What Are the Primary Growth Drivers for the Histone Deacetylase (HDAC) Inhibitors Market?
The increasing prevalence of neurodegenerative diseases is anticipated to fuel the expansion of the histone deacetylase (HDAC) inhibitors market in the future. Neurodegenerative diseases, distinguished by the continuous degeneration and neuron mortality in the brain and spine, result in cognitive and motor impairment, including conditions like Alzheimer's, which is identified by memory deterioration and cognitive regression due to amyloid buildups and tau structures. The escalating prevalence of neurodegenerative diseases can be linked to numerous elements, including age, lifespan, genetic makeup, and environmental influences. Histone deacetylase (HDAC) inhibitors are being investigated as potential therapies for neurodegenerative diseases due to their capability to control gene articulation and offer neuroprotective effects. For example, in August 2024, as per the Centers for Disease Control and Prevention, a federal organization based in the United States, approximately 6.7 million senior adults currently have Alzheimer's disease, a figure projected to surge to almost 14 million by 2060 in the US. Consequently, the escalating prevalence of neurodegenerative diseases is propelling the advancement of the histone deacetylase (HDAC) inhibitors market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18386&type=smp

Who Are the Major Industry Players Fueling Histone Deacetylase (HDAC) Inhibitors Market Expansion?
Major companies operating in the histone deacetylase (HDAC) inhibitors market are Bristol-Myers Squibb Company, Novartis AG, Merck KGaA, Abcam plc, Pharmacyclics LLC, R&D Systems Inc., Tenaya Therapeutics Inc., Syndax Pharmaceuticals Inc., Italfarmaco SpA, InvivoGen Corporation, TCI Chemicals (India) Pvt. Ltd., 4SC AG, Medivir AB, Mirati Therapeutics Inc., Spectrum Pharmaceuticals Inc., Curis Inc., Acetylon Pharmaceuticals Inc., Oryzon Genomics SA, Xynomic Pharmaceuticals Inc., Celleron Therapeutics Ltd., Midatech Pharma PLC, Karus Therapeutics Ltd., Shenzhen Chipscreen Biosciences Co. Ltd.

Which Key Developments Are Influencing the Histone Deacetylase (HDAC) Inhibitors Market?
Key players in the histone deacetylase (HDAC) inhibitors market are concentrating their efforts on creating novel solutions like HDAC inhibitors for cancer therapy to improve effectiveness and minimize side effects. Histone deacetylase (HDAC) inhibitors are types of pharmaceutical products utilized for treating cancer. They operate by restricting the action of HDAC enzymes, commonly responsible for removing acetyl groups from the histone proteins. The impediment results in an escalation of histone acetylation, leading to modifications of chromatin structure and impacting gene enunciation. For instance, in September 2023, Shuttle Pharmaceuticals Holdings Inc., an American firm focusing on the development of cancer breakthrough therapies, received recognition from the U.S. Patent and Trademark Office in the form of new HDAC Inhibitor Patents for Cancer Treatment. These advanced inhibitors are customized to aim at particular HDAC enzymes involved in the advancement of cancer, with the objective of interfering with anomalous gene expression sequences that lead to tumor enlargement and metastasis. These proprietary compounds show heightened potency and selectivity, reducing unintended effects and enhancing safety profiles for patients under treatment.

How Is the Segmentation of the Histone Deacetylase (HDAC) Inhibitors Market Defined?
The histone deacetylase (HDAC) inhibitors market covered in this report is segmented -

1) By Class: Class I HDACs, Class II HDACs, Class III HDACs, Class IV HDACs
2) By Route Of Administration: Oral HDAC Inhibitors, Parenteral HDAC Inhibitors
3) By Application: Oncology, Neurology, Other Applications
4) By End User: Hospitals, Academic And Research Institutes, Pharmaceutical Companies, Other End Users

Subsegments
1) By Class I HDACs: HDAC1, HDAC2, HDAC3, HDAC8
2) By Class II HDACs: HDAC4, HDAC5, HDAC6, HDAC7, HDAC9, HDAC10
3) By Class III HDACs (Sirtuins): SIRT1, SIRT2, SIRT3, SIRT4, SIRT5, SIRT6, SIRT7
4) By Class IV HDACs: HDAC11

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/histone-deacetylase-hdac-inhibitors-global-market-report

What Is the Leading Region in the Histone Deacetylase (HDAC) Inhibitors Market?
North America was the largest region in the histone deacetylase (HDAC) inhibitors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the histone deacetylase (HDAC) inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Histone Deacetylase (HDAC) Inhibitors Global Market Report?

- Market Size Analysis: Analyze the Histone Deacetylase (HDAC) Inhibitors Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Histone Deacetylase (HDAC) Inhibitors Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Histone Deacetylase (HDAC) Inhibitors Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Histone Deacetylase (HDAC) Inhibitors Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18386

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.